S4. Summary of the GALNS assay validation. Intra-assay variation (within-run precision)

Similar documents
vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Development and Validation of a Polysorbate 20 Assay in a Therapeutic Antibody Formulation by RP-HPLC and Charged Aerosol Detector (CAD)

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Comparison of Biotage Extrahera vs. Manual Sample Processing Using a Vacuum Manifold

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

Development and Validation of a New Uv Method for the Analysis of Rebamipide

J Pharm Sci Bioscientific Res (4): ISSN NO

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Validation Report 23 B

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Determination of Bath Salts (Pyrovalerone Analogs) in Biological Samples

RayBio Human Granzyme B ELISA Kit

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

CHAPTER 3: ANALYTICAL METHOD DEVELOPMENT AND VALIDATION

S.C. Moldoveanu, A.G. Hudson, A. Harrison. R.J. Reynolds Tobacco Co.

Corresponding Author:

International Journal of Pharma and Bio Sciences

M. Kratzel. Two Examples of interactive elearning

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

Simultaneous determination of triacetin, acetic ether, butyl acetate and amorolfine hydrochloride in amorolfine liniment by HPLC

Development and validation of UV spectrophotometric estimation of lisinopril dihydrate in bulk and tablet dosage form using area under curve method

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

210 J App Pharm Vol. 6; Issue 2: ; April, 2014 Mustafa et al, 2014

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

Validation Report 8. EURL for Cereals and Feeding stuff National Food Institute Technical University of Denmark

1 Analytical Methods 2 3 Electronic Supplementary Information Ultra-trace determination of sodium fluoroacetate (1080) as

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

PKU (Phenylketonuria) Serum HPLC Analysis Kit User Manual

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

Insulin (Porcine/Canine) ELISA

RayBio Human ENA-78 ELISA Kit

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

DKK-1 ELISA, Cat.No. BI For the quantitative determination of DKK-1 in human serum

RayBio Human Thyroglobulin ELISA Kit

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

Int. Res J Pharm. App Sci., 2012; 2(3):22-28

ISSN (Print)

Electronic Supporting Information

Humco Compounding, 313 East 12th Street, Suite 230, Austin, TX 78701, USA; Tel.:

Highly Repeatable Ultra Low Detection of Estradiol Using Triple Quadrupole GC/MS in NCI Mode

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

VU Biostatistics and Experimental Design PLA.216

The present manuscript describes simple, sensitive, rapid, accurate, precise and cost effective First derivative

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Carnitine / Acylcarnitines Dried Blood Spots LC-MS/MS Analysis Kit User Manual

Analysis of short chain organic acids in tobacco and in some flavored e-liquids

IJRPC 2013, 3(1) Gandhi et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Determination of red blood cell fatty acid profiles in clinical research

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Development and Validation of a UV-Spectrophotometric Method for Quantification of Atorvastatin in Tablets

Dry eye disease commonly known as atopic keratoconjunctivitis is an autoimmune disease of

36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Pelagia Research Library

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Real-time PK Measurement of the Chemotherapeutic Drug Melphalan in Whole Blood by a Novel PaperSpray Mass Spectrometry

Estimation of zolmitriptan by a new RP-HPLC method

EliKine Free Thyroxine (ft4) ELISA Kit

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

25-Hydroxyvitamin D2-D3 Serum VD-200 UHPLC Analysis Kit User Manual

Manual. Transfer step. Figure 1. Workflow comparison of manual phenylalanine assay and automated GSP Neonatal Phenylalanine assay

Accuracy and Precision. Intra- and inter-assay accuracy and precision for both rifapentine

Journal of Pharmacreations

Screening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum

human Total Cathepsin B Catalog Number: DY2176

Development and Validation of an UPLC-MS/MS Method for Quantification of Mycotoxins in Tobacco and Smokeless Tobacco Products

Method Development and Validation for Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Dosage Form by HPLC

Development and Validation of UV- Spectrophotometric Method for Estimation of Simvastatin in Bulk and Solid Dosage Form.

Analytical Method Development and Validation for the Estimation of Guaifenesin and Dextromethorphan by RP-HPLC

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Rat Insulin ELISA. For the quantitative determination of insulin in rat serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

Mouse C-Peptide ELISA Kit

UV Spectrophotometric Estimation of Alprazolam by Area Under Curve And First Order Derivative Methods in Bulk and Pharmaceutical Dosage Form

Pelagia Research Library

Scholars Research Library

Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC

Validated Spectrophotometric Method for Simultaneous Estimation of Atorvastatin and Nicotinic acid in Combined Pharmaceutical dosage form

Development and Validation of Multiresidue Pesticide Methods at FDA/CFSAN

DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Fast, Robust and Reliable Method for the Identification and Quantitation of Sildenafil Residue in Honey using LC-MS/MS

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Airo International Research Journal ISSN : Volume : 7 October 2015

Transcription:

S4. Summary of the GALNS assay validation (i.) Intra-assay variation (within-run precision) Intra-assay variation was determined by measuring standard blood samples (low activity standard; medium activity standard; high activity standard) 6 times in a single batch. The results, summarized in S4.1.Table, show that relative standard deviation or RSD % (variability coefficient) was <15% for samples with enzymatic activity. The experiment concluded that there is no significant intra-assay variation. Intra assay variation results for standard blood samples standard blood sample N=6 mean activity std rsd % Low activity standard 3.36 0.17 5.10 Medium activity standard 11.68 1.63 14.02 High activity standard 17.47 1.55 8.85 std - standard deviation; rsd relative standard deviation (ii.) Inter assay variation (between-run precision) Inter-assay variation was determined by measuring the standard blood samples (low activity standard; medium activity standard; high activity standard f), 1 pathological sample and 1 normal control in 5 different days, in separate batches. The results, summarized in S4.2.Table, show no significant inter-assay variation between aliquots of the same sample with RSD% < 15%. Inter assay variation results for standard blood samples blood sample N=5 mean activity std rsd (%) Low activity standard 3.94 0.38 9.6 Medium activity standard 11.67 1.06 9.1 High activity standard 18.14 2.08 11.5 MPS IV a patient 0.64 0.07 10.9 Normal Control* 15.24 1.28 8.4 *Normal control is here defined as a blood sample from a healthy individual with normal GALNS activity std - standard deviation; rsd relative standard deviation 1

(iii.) Specificity of the method MRM-MS transitions monitored in MPS IVa assay No Analyte Unique transition to be monitored 1 4- MU 175.0/119.0 2 Internal standard 217.0/160.0 Matrix effect on the MS analysis was investigated in 5 routine determinations. The ratio of the IS intensity in blank (filter paper, no blood) to the IS intensity in pathological control sample (containing blood matrix). The ratio of the IS in blank vs. blood samples was found to be 1.0 +/-0.1 showing no matrix interference. Matrix interference in the MPS IVA determinations M IS DBS: M IS B Mean (N=5) 1.0 std 0.13 rsd% 13.6 std - standard deviation; rsd relative standard deviation (iv.) Accuracy of the determination Within- and between-run accuracy of the determination Within run accuracy (N=6) Nominal Concentration ng/ml Mean Accuracy std rsd% 2.4 105.7 15.9 15.0 1050.0 99.3 3.6 3.6 2250.0 100.2 2.0 2.0 4400.0 99.8 3.3 3.3 Between run accuracy (N=6, E=2) Nominal Concentration Mean Accuracy std rsd% 2.4 105.8 0.2 0.2 1050.0 99.1 0.3 0.3 2250.0 100.0 0.3 0.3 4400.0 99.2 0.9 0.9 N=no of aliquots pro sample, E=no of experiments performed 2

(v.) Standard linearity of the 4-MU Standard curve performed with solutions obtained directly by diluting a concentrated solution of the analyte - 4MU. Standard curve performed on each measured plate with solutions prepared in the same manner as the blood samples (dilution in reaction buffers, liquid-liquid extraction, evaporation, dissolving in HPLC solvents). 3

(vi.) Normal control reference values GALNS activity in DBS from normal controls samples Number of samples (n=57) GALNS activity minimum 11.0 maximum 43.0 mean 23.1 standard deviation 8.9 CUT OFF (mean-2*std) 5.3 (vii.) GALNS activity in pathological samples GALNS activity in DBS from MPS IVA patients Number of samples (n=24) GALNS activity minimum 0.00 maximum 0.64 mean 0.35 standard deviation 0.21 Case study: Case of a family with MPS IVA patients: both parents are carriers but not affected and the two children both with severe symptoms of Morquio A syndrome. DBSs were obtained from fresh EDTA blood, and on these samples GALNS activity was measured using the protocol described in part 2. The results show a very reduced GALNS activity in DBSs from the children, while the DBSs from the parents present normal GALNS activity. GALNS activity in DBS from a family with MPS IVA patients 4

(viii.) NPV and PPV Patients with MPS4a (as confirmed on molecular genetics) Condition positive Condition negative MPS 4a enzymatic assay Test outcome positive Test outcome negative True positive (TP) = 24 False negative (FN) = 0 False positive (FP) = 0 True negative (TN) = 57 Positive predictive value = TP / (TP + FP) Negative predictive value = TN / (FN + TN) Sensitivity = TP / (TP + FN) Specificity = TN / (FP + TN) (ix.) Limit of detection LOD and LOQ of GALNS enzymatic product in DBS Blank control (N0) GALNS activity () Standard deviation 0.03 LOD (3*standard deviation) 0.1 LOQ (10*standard deviation) 0.3 5

(x.) Robustness of the method Results of the robustness experiment samples stability of the samples after clean-up (plates covered, at room temperature for 0 h, 24 h and 48 h) Low activity Medium activity High activity Base pool standard standard standard Mean 0.65 2.54 11.22 19.67 0 h Std. Deviation 0.50 0.18 3.00 3.42 Std. Error 0.20 0.07 1.22 1.40 Mean 0.30 2.42 10.04 16.80 24 h Std. Deviation 0.16 0.27 1.71 2.62 Std. Error 0.06 0.11 0.70 1.07 Mean 0.28 2.66 11.71 22.43 48 h Std. Deviation 0.12 0.51 0.82 4.20 Std. Error 0.05 0.21 0.34 1.71 ANOVA One way analysis of variance P value 0.098 0.530 0.376 0.413 P value summary ns ns ns ns Are means signif. different? (P < 0.05) No No No No Number of groups 3 3 3 3 F 2.718 0.664 1.046 0.939 R squared 0.266 0.086 0.122 0.111 ns = no significance; P = permutation values; F = distribution with degrees of freedom; R 2 = multiple correlation coefficient squared Robustness of the assay basepool, low, medium and high activity blood samples measured at 0 h, 24 h and 48 h after sample preparation 6

(xi.) Linearity of the GALNS enzymatic activity Linearity of the enzymatic reaction using standard blood samples: Standard blood samples were obtained in Centogene Laboratories using a blood sample with high activity of the lysosomal enzymes according with de Jessus et al. (2009): basepool (0% activity from the original enzymatic activity); low activity standard (5% activity from the original enzymatic activity); medium activity standard (50% activity from the original enzymatic activity); and high activity standard (100% activity from the original enzymatic activity). Linearity of the enzymatic reaction using different volumes of DBS extract (different amount of sample): 4 different punches from the same sample were subjected to extraction.volumes corresponding to 0 %, 25 %, 50 %, 75 %, and 100 % of normal volume of sample were further used for the next steps of the assay, brought to normal volume with 0,2% BSA solution. The volume of sample and the results of the enzymatic assay were plotted and found to be linear 7